New Key Statistics Module, Z-Score and F-Score
NYSE:ENZ Key Ratios
| Market Cap $ M | 54.30 |
| Enterprise Value $ M | 1.24 |
| P/E(ttm) | 1.58 |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.76 |
| Price/Sales | 4.14 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | 1.92 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 12.00 |
| EPS (TTM) $ | 0.67 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.27 |
| EV-to-EBITDA | -0.45 |
| PEG | -- |
| Shares Outstanding M | 51.23 |
| Net Margin (%) | 254.30 |
| Operating Margin % | -35.44 |
| Pre-tax Margin (%) | -75.00 |
| Quick Ratio | 2.89 |
| Current Ratio | 3.20 |
| ROA % (ttm) | 34.22 |
| ROE % (ttm) | 59.15 |
| ROIC % (ttm) | -10.33 |
| Dividend Yield % | -- |
| Altman Z-Score | -2.25 |
ENZ Number of Guru Trades
ENZ Volume of Guru Trades
Gurus Latest Trades with NYSE:ENZ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:ENZ is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Enzo Biochem Inc Insider Transactions
No Available Data
News about NYSE:ENZ
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers